Catechin is present as metabolites in human plasma after consumption of red wine

Journal of Nutrition

Volumn 129, Issue 9, 1999, Pages 1662-1668

  Donovan, Jennifer L ^a   Bell, Jennifer R ^a   Kasim Karakas, Sidika ^a   German, J Bruce ^a   Walzern, Rosemary L ^a   Hansen, Robert J ^a   Waterhouse, Andrew L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catechin; Flavonoids; Humans; Metabolites; Wine

Indexed keywords

ALCOHOL; CATECHIN; FLAVONOID; MECIADANOL; PHENOL DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; FOOD ANALYSIS; FOOD COMPOSITION; GLUCURONIDATION; HEART PROTECTION; HUMAN; HUMAN EXPERIMENT; MALE; METHYLATION; NORMAL HUMAN; SULFATION; WINE;

EID: 0032866430     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/129.9.1662     Document Type: Article

References (48)

1. Criqui, M. H. & Ringel, B. L. (1994) Does diet or alcohol explain the French paradox? Lancet 344: 1719-1723.
2. Das, N. P. (1971) Studies or flavonoid metabolism, absorption and metabolism of (+)-catechin in man. Biochem. Pharmacol. 20: 3435-3445.
3. 14C]-catechin. Biochem. J. 125: 417-423.
4. Demrow, H. S., Slane, P. R. & Folts, J. D. (1995) Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 91: 1182-1188.
5. de Vries, J.H.M., Hollman, P.C.H., Meyboom, S., Busyman, M.N.C.P., Zock, P. L., van Staveren, W. A. & Katan, M. B. (1998a) Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am. J. Clin. Nutr. 68: 60-65.
6. de Vries, J.H.M., Hollman, P.C.H., Olthof, M. R. & Katan, M. B. (1998b) Absorption of quercetin from red wine. Eur. J. Clin. Nutr. 52: S88 (abs.).
7. Donovan, J. L., Luthria, D. L., Stremple, P. & Waterhouse, A. L. (1999) Analysis of (+)-catechin, (-)-epicatechin and their 3′ and 4′ O-methylated analogs: a comparison of sensitive methods. J. Chromatogr. B. 726: 277-283.
8. Fitzpatrick, D. F., Hirschfield, S. L. & Coffey, R. G. (1993) Endothelium-dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol. 265: H774-H778.
9. Frankel, E. N., Kanner, J., German, J. B., Parks, E. & Kinsella, J. E. (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457.
10. Frankel, E. N., Waterhouse, A. L. & Teissedre, P. L. (1995) Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low density lipoprotein. J. Agric. Food Chem. 43: 890-894.
11. Fuhr, U. & Kummert, A. L. (1995) The fate of naringin in humans: a key to grapefruit juice-drug interactions. Clin. Pharmacol. Ther. 58: 365-373.
12. Gibaldi, M. (1991) Biopharmaceutics and Clinical Pharrnacokinetics, pp. 1-23, 377. Lea and Febiger, Philadelphia, PA.
13. Giles, A. R. & Gumma, A. (1973) Biopharmaceutical evaluation of cyanidanol tablets using pharmacokinetic techniques. Arzneim.-Forsch. 23: 98-100.
14. Gronbæk, M., Deis, A., Sorensen, T.I.A., Becker, U., Schnohr, P. & Jensen, G. (1995) Mortality associated with moderate intakes of wine, beer and spirits. Br. Med. J. 310: 1165-1169.
15. 14C]-cyanidanol-3 in man following oral administration. Xenobiotica 13: 279-283.
16. Hackett, A. M., Shaw, I. C. & Griffiths, L. A. (1982) 3′-O-Methyl-(+)-catechin glucuronide and 3′-O-methyl-(+)-catechin sulfate: new urinary metabolites of (+)-catechin in the rat and the marmoset. Experientia 38: 538-540.
17. Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A. & Aviram, M. (1997) Reduced progression of atherosclerosis in apolipopritein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17: 2744-2752.
18. Hertog, M.G.L, Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A., Nedeljkovic, S., Pekkarinen, M., Simic, B. S., Toshima, H., Feskens, J. M., Hollman, C. H. & Katan, M. B. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155: 381-386.
19. Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, J. B. & Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342: 1007-1011.
20. Hobbs, W. R., Rall, T. W. & Verdoorn, T.A. (1996) Hypnotics and sedatives; ethanol. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics (Hardman, J. G., Limbard, L. E., Molinoff, P. B., Ruddon, R. W. & Gilman, A. G., eds.), pp. 361-397. McGraw-Hill, New York, NY.
21. Hollman, P.C.H., de Vries, J.H.M., van Leeuwen, S. D., Mengelers, M.J.B. & Katan, M. B. (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62: 1276-1282.
22. Hollman, P.C.H., Gaag, M.V.D., Mengelers, M.J.B., van Trijp, J.M.P., de Vries, J.H.M. & Katan, M. B. (1996) Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 21: 703-707.
23. Hollman, P.C.H., Trijp, J.M.P., Mengelers, M.J.B., de Vries, J.H.M. & Katan, M. B. (1997) Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett. 114: 139-140.
24. Klatsky, A. L. & Armstrong, M. A. (1993) Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? Am. J. Cardiol. 71: 467-469.
25. Kühnau, J. (1976) The flavonoids, a class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet 24: 117-191.
26. Lapidot, T., Harel, S., Granit, R. & Kanner, J. (1998) Bioavailability of red wine anthocyanins as detected in human urine. J. Agric. Food Chem. 46: 4297-4302.
27. Lee, M. J., Wang, Z. Y., Li, H., Chen, L., Sun, Y., Gobbo, S., Balentine, D. A. & Yang, C. S. (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomark. Prev. 4: 393-399.
28. Luthria, D. L., Jones, A. D., Donovan, J. L. & Waterhouse, A. L. (1997) GC-MS determination of catechin and epicatechin levels in human plasma. J. High Res. Chromatogr. 20: 621-623.
29. Macheix, J.-J., Fleuriet, A. & Billot, J. (1990) In: Fruit Phenolics, pp. 70, 324. CRC Press, Boca Raton, FL.
30. Morand, C., Crespy, V., Manach, C., Besson, C., Demigné, C. & Rémésy, C. (1998) Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. 44: 212-219.
31. Paganga, G., Al-Hashim, H., Khodr, H., Scott, B. C., Aruoma, O. I., Hider, R. C., Halliwell, B. & Rice-Evans, C. A. (1996) Mechanisms of antioxidant activities of quercetin and catechin. Redox Report (1996) 359-364.
32. Paganga, G. & Rice-Evans, C. A. (1997) The identification of flavonoids as glycosides in human plasma. FEBS Lett. 401: 78-82.
33. Renaud, S. & de Lorgeril, M. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526.
34. Renaud, S. & Ruff, J. C. (1995) Effects of alcohol on platelet functions. Clin. Chim. Acta 246: 77-89.
35. Richelle, M., Tavazzi, I., Enslen, M. & Offord, EA. (1999) Plasma kinetics in man of epicatechin from black chocolate. Eur. J. Clin. Nutr. 53: 22-26.
36. Rimm, E. B., Klatsky, A., Grobbee, D. & Stampfer, M. J. (1996) Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? Br. Med. J. 312: 731-736.
37. Rozman, K. K. & Klaassen, C. D. (1996) Absorption, distribution and excretion of toxicants. In: Casarett & Doull's Toxicology: The Basic Science of Poisons (Klaasen, K.K., ed.), pp. 91-112. McGraw-Hill, New York, NY.
38. Sasaki, S. & Kesteloot, H. (1994) Wine and non-wine alcohol: differential effect on all-cause and cause-specific mortality. Nutr. Metab. Cardiovasc. Dis. 4: 177-182.
39. 2 release is stimulated by wine in vitro: one mechanism that may mediate the vasoprotective effects of wine. Nutr. Biochem. 8: 647-651.
40. Shaw, I. C. & Griffiths, L. A. (1980) Identification of the major biliary metabolite of (+)-catechin in the rat. Xenobiotica 10: 905-911.
41. Shaw, I. C., Hackett, A. M. & Griffiths, L. A. (1982) Metabolism and excretion of the liver-protective agent (+)-catechin in experimental hepatitis. Xenobiotica 12: 405-416.
42. St. Leger, A. S., Cochrane, A. L. & Moore, F. (1979) Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 339: 1017-1020.
43. Vinson, J. A., Dabbagh, Y. A., Serry, M. M. & Jang, J. (1995) Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J. Agric. Food Chem. 43: 2800-2802.
44. Watanabe, S., Yamaguchi, M., Sobue, T., Takahashi, T., Miura, T. Arai, Y., Mazur, W., Wahala, K. & Adlercreutz, H. (1998) Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (Kinako). J. Nutr. 128: 1710-1715.
45. Waterhouse, A. L., Price, S. F. & McCord, J. D. (1998) Reversed-phase high-performance liquid chromatography methods for analysis of wine polyphenols. Methods Enzymol. 299: 113-121.
46. Weiner, F. R., Czaja, M. J. & Zern, M. A. (1988) Ethanol and the liver. In: The Liver: Biology and Pathobiology (Arias, I. M., Jakoby, W. B., Popper, H., Schachter, D. & Shafritz, D. A., eds.), p. 1181. Raven Press, New York, NY.
47. Wermeille, M., Turin, E. & Griffiths, L A. (1983) Identification of the major urinary metabolites of (+)-catechin and 3-O-methyl-(+)-catechin in man. Eur. J. Drug Metab. Pharmacokinet. 8: 77-84.
48. Xu, R., Yokoyama, W. H., Irving, D., Rein, D., Walzem, R. L. & German, J. B. (1998) Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis 137: 29-36.